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Abstract We previously reported that, in human Hsp90 (hHsp90), there are 4 highly 
immunogenic sites, designated sites Ia, Ib, Ic, and II (Nemoto et al 1997).  The present 
study was performed to further characterize their epitopes and to identify the epitope 
that is potentially common to all members of the Hsp90 family.  Panning of a bacterial 
library carrying randomized dodecapeptides revealed that Glu251-Ser-X-Asp254 
constituted site Ia and that Pro295-Ile-Trp-Thr-Arg299 did so site Ic.  Site II 
(Asp701-Pro717) was composed of several epitopes.  When 19 anti-hHsp90 monoclonal 
antibodies (mAbs) were subjected to immunoblotting against recombinant forms of 7 
Hsp90-family members, 2 mAbs (K41110 and K41116C) that recognized site Ic bound 
to yeast Hsp90 with affinity identical to that for hHsp90; and one (K3729) that 
recognized Glu222-Ala231 of hHsp90b could bind to human Grp94, an endoplasmic 
reticulum paralog of Hsp90.  Among the 5 amino acids constituting site Ic, Trp297 and 
Pro295 were essential for recognition by all anti-site-Ic mAbs and Arg299 was important 
for most of them.  The necessity of Ile296, Thr298, and Arg299, which are replaced by 
Leu, Met/Leu, and Lys, respectively, in some eukaryotic Hsp90, was dependent on the 
mAbs, and K41110 and K41116C could react with Hsp90s carrying these substitutions.  
From these data taken together, we propose that the penta-peptide 
Pro295-Ile-Trp-Thr-Arg299 of hHsp90 functions as an immunodominant epitope common 





Heat shock proteins (Hsps) exist essentially in all organisms.  Reflecting their 
important and general roles as molecular chaperones, their amino acid sequences are 
highly conserved in every Hsp family even among eukaryotic and prokaryotic 
organisms.  For instance, the amino acid sequences of Hsp60 (Venner et al 1990), 
Hsp70 (Hunt and Morimoto 1985), and Hsp90 (Hickey et al 1989; Rebbe et al 1987) of 
human cells are 48.2, 47.2, and 35.6% identical to their respective E. coli orthologs, 
GroEL (Hemmingsen et al 1988), DnaK (Bardwell and Craig 1984), and HtpG 
(Bardwell and Craig 1987).   
The sequence homology of Hsps led to the hypothesis that the immune system could 
be triggered by bacterial antigens:  Bacterial GroEL, for instance, shares a high degree 
of homology with host ortholog, which may result in an aberrant immune response and 
chronicity of inflammation (Ranney 1982; Tabeta et al 2000; Loesche et al 1985).  
However, it remains unknown whether or not the sequence homology of the Hsp family 
proteins is sufficient for all members of the family to share the same immunogenicity. 
Hsp90 is composed of three domains, i.e. N-terminal, middle and C-terminal domains.  
The N-terminal domain (amino acids 1 – 220/230) carries an 
ATP/geldanamycin-binding site (Prodormou et al 1997a; Stebbins et al 1997).  The 
N-terminal domain of human (Stebbins et al 1997) and yeast Hsp90 (Prodromou et al 
1997a) and the middle domain of yeast Hsp90 (Meyer et al 2003) have been reported.  
Based on the results of crystallographic studies and the similarity of the structure, a 
molecular clamp model on the client binding has been proposed (Prodromou et al 
1997b; Prodromou et al 2000; Meyer et al 2003).  The C-terminal domain (c.a. 200 
residues) is responsible for the dimerization (Minami et al 1994; Nemoto et al 1995).  
The three-dimensional structure of the C-terminal domain of Hsp90 remains unknown.  
Only the C-terminal half (amino acids 511-624) of the C-terminal domain of HtpG, a 
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bacterial ortholog of mammalian Hsp90, has been reported (Harris et al 2004).  Recent 
studies indicate that the middle domain carries the client binding site (Meyer et al 2003), 
although an additional binding site might be present in the C-terminal domain (Young et 
al 1997: Scheibel et al 1998; Minami et al 2001; Harris et al 2004). 
We previously produced 33 monoclonal antibodies (mAbs) against 2 isoforms of 
human Hsp90, i.e., Hsp90a (hHsp90a) and Hsp90b (hHsp90b) (Nemoto et al 1997).  
Epitope mapping analysis by use of an enzyme-linked immunosorbent assay (ELISA) 
with deletion mutants and an octa-peptide multipin library demonstrated the existence 
of 4 highly immunogenic sites, designated sites Ia (amino acids 247-257); Ib (amino 
acids 263-270); Ic (amino acids 291-304); and II (amino acids 702-716).  Sites Ia and 
Ib were localized within the highly charged region (amino acids 223-289) of hHsp90a; 
site Ic, C-terminally adjacent to the charged region; and site II, near the C-terminus.  
The amino acid sequences constituting sites Ia, Ib, and II vary between hHsp90a and 
hHsp90b.  The highly charged region and the C-terminal one are dispensable for the 
growth of budding yeast (Borkovich et al 1989) and deleted in HtpG, the bacterial 
ortholog.  In contrast, the amino acid sequence of site Ic is highly conserved in 
eukaryotic Hsp90, and is relatively conserved in all organisms (see Table 8).  
We recently compared the immunogenic property of the Hsp90 molecular chaperone 
with polyclonal (pAbs) raised against various species of Hsp90-family member and 
monoclonal antibodies (mAbs) raised against human Hsp90 (hHsp90) (Kawano et al 
2004).  Among 33 mAbs developed against hHsp90a and hHsp90b, several mAbs that 
strongly reacted with yeast Hsc82 (yHsc82) recognized Asn291-Ile304, a conserved region 
of the family protein.  The polyclonal antibody raised bacterial ortholog HtpG did not 
cross-react with hHsp90a and hHsp90b, human Grp94 (hGrp94) and human Trap1 
(hTrap1), and vice versa.  Hence, although mammalian Hsp90 shares some 
immunological reactivity with yHsc82, it is considerably distinct from its bacterial 
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ortholog, HtpG. from Escherichia coli (EcHtpG) and Porphyromonas gingivalis 
(PgHtpG) (Kawano et al 2004). 
In the present study, we further characterized the epitopes of the anti-Hsp90 mAbs by 
a panning technique that selects the 12-amino acid sequences specifically recognized by 
the anti-Hsp90 mAbs.  We found that 2 mAbs that recognized site Ic reacted with 








The materials used and their sources were the following: Expression vector pQE9 and 
plasmid pREP4, from Qiagen Inc. (Chatsworth, CA, USA); expression vector pTrcHis 
TOPO and TOP10 competent cells, from Invitrogen (Carlsbad, CA, USA); 
CNBr-activated Sepharose 4B and low-molecular-weight markers from Amersham 
Biosciences (Piscataway, NJ, USA); Wizard genomic DNA purification kit, from 
Promega Corp. (Madison, WI, USA); kaleidoscope prestained standards, from Bio-Rad 
(Richmond, CA, USA); restriction enzymes and DNA-modifying enzymes, from 
Nippon Gene (Tokyo, Japan); Talon metal affinity resin, from Clontech Laboratories Inc. 
(Palo Alto, CA, USA); anti-Hsp90 mAb AC88/SPA-830 from Stressgen Biotech Corp. 
(Victoria, B.C., Canada); alkaline-phosphatase-conjugated rabbit anti-mouse 
Ig(G+A+M) from Zymed Laboratories Inc. (San Francisco, CA, USA). 
 
Construction of bacterial expression vectors 
 
Construction of plasmids carrying the full-length form of hHsp90a, hHsp90b, hGrp94, 
EcHtpG, and PgHtpG, and plasmids carrying the N domain of EcHtpG (residues 1-336, 
designated EcHtpG-N) and hHsp90a (residues 1-400, hHsp90a-N) tagged with a 
histidine hexamer encoded by pQE9 were described previously (Kawano et al 2004; 
Nemoto et al 1996; Roi 1998; Nemoto et al 2001).  Y1090[pREP4] was transformed 
with the plasmids and transformants were selected on Luria broth agar plates containing 
50 mg/ml of ampicillin and 25 mg/ml of kanamycin. 
Plasmids encoding full-length forms of yHsc82 (Borkovich et al 1989) and hTrap1 
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(Chen et al 1996; Song et al 1995) were generously provided by Drs. Y. Kimura (Tokyo 
Metropolitan Institute of Medical Science, Tokyo, Japan) and W.-H. Lee (the University 
of Texas, San Antonio, Texas, USA), respectively.  For construction of yHsc82 and 
hTrap1, DNA fragments encoding the full-length forms were amplified by PCR, and 
then directly inserted into the pTrcHis TOPO expression vector in frame according to 
the manufacturer’s recommendation.  TOP10 cells were transformed with the plasmids 
and selected on Luria broth agar plates containing 50 mg/ml of ampicillin.  The 
insertion and orientation of the DNA fragments were confirmed by conducting Hot Star 
PCR (Qiagen Inc., Chatsworth, CA, USA).  The constructed plasmids were designated 
pTrcHis-yHsc82 and pTrcHis-hTrap1, respectively. 
 
In vitro mutagenesis 
 
Nucleotides ATC encoding Ile296, TGG encoding Trp297, ACC encoding Thr298, and 
AGA encoding Arg299 of hHsp90a-N were substituted with CTC encoding Leu296, GGG 
encoding Gly297, ATG encoding Met298, and GGA encoding Gly299, respectively, by 
PCR-based site-directed mutagenesis in combination with DpnI cleavage of a template.  
pQE9-hHsp90a-N (residues 1-400) was this template.  As a result, pQE9-hHsp90a-N 
Trp297Gly, Thr298Met, Arg299Gly, and a double mutant Ile296Leu/Thr298Met were 
constructed.  Mutagenesis was confirmed by DNA sequencing.   
 
Expression and purification of recombinant proteins 
 
After overnight cultivation of  transformed bacteria at 37oC, recombinant proteins 
were expressed at 30oC for 4 h in the presence of 0.2 mM 
isopropyl-b-D-thiogalactopyranoside.  They were purified by affinity chromatography 
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with a Talon affinity column according to the manufacturer’s protocol except that 10 
mM imidazole and 10 mg/ml of leupeptin were added to the lysis buffer [20 mM 
Tris-HCl, pH 8.0, containing 0.1 M NaCl and 0.5 mg/ml lysozyme].  After extensive 
washing with washing buffer [20 mM Tris-HCl, pH 8.0, 0.1 M NaCl containing 10 mM 
imidazole] to remove non-adsorbed proteins, the bound proteins were eluted with 0.1 M 
imidazole (pH 8.0) containing 10% (v/v) glycerol.  Purified proteins were used 
immediately or stored at -80oC until used. 
 
Production of polyclonal antibody (pAb) 
 
Affinity-purified recombinant EcHtpG-N (amino acids 1-336) was further purified by 
electrophoresis on a 7.5% polyacrylamide gel of 0.5-cm thickness under nondenaturing 
conditions (Nemoto et al 1995).  A separated protein was excised following 
visualization with a Gelcode silver snap kit (Pierce, Rockford, IL, USA).  A piece of a 
polyacrylamide gel containing the recombinant protein was homogenized, and then 
injected into rabbits (Japan White) 5 times at 3-week intervals.  The immunogen 
(approximately 1 mg) emulsioned with Freund’s complete adjuvant was used for 
primary immunization, and subsequent booster injections were given with it in Freund’s 
incomplete adjuvant.  Polyclonal antibodies were purified by use of 
EcHtpG-N-conjugated CNBr-activated Sepharose (Amersham Biosciences) prepared 
according to the manufacturer’s recommendation.  Antisera and pH-neutralized, 
purified pAb were divided into small aliquots and stored in the presence of 0.03% NaN3 
at –80oC.  Animal care and experimental procedures were conducted in accordance 
with the Guidelines for Animal Experimentation of Nagasaki University with the 





K3700 and K41000 number series represent the mAbs produced from hybridoma cells 
of mice immunized with hHsp90b and hHsp90a, respectively (Nemoto et al 1997).  
By setting 1% as the threshold for the binding affinity to one hHsp90 isoform, we 
classified 10 (Fig. 1, indicated by bold letters) and 3 mAbs (indicated by bold italic 
letters) to be specific for hHsp90a and hHsp90b, respectively; and 19 mAbs reactive 
with both Hsp90 isoforms (indicated by non-bold letters).  The mAb K3725A 
remained to be characterized because of its unusual behavior.  The recognition sites of 
the 33 mAbs were described previously, which comprised 4 highly immunogenic sites, 
designated sites Ia, Ib, Ic, and II (Fig. 1 and Nemoto et al 1997). 
 
Enzyme-linked immunosorbent assay (ELISA) 
 
The binding affinity of the antibodies for the Hsp90-family proteins was determined by 
ELISA.  Purified proteins (1 mg) coated on each well of a Maxisorp C96 titer plate 
(Nalge Nunc Int., Rochester, NY, USA) were incubated with various concentrations of 
purified mAbs in 0.1 ml of the blocking buffer [0.17 M H3BO4, pH 8.5, containing 0.12 
M NaCl, 0.05% (v/v) Tween20, 1mM EDTA, and 0.05% (w/v) NaN3 and 0.25% (w/v) 
bovine serum albumin] for 2 h at room temperature as reported previously (Hornbeck et 
al 1994).  Following a 1-h incubation with the anti-mouse Ig(G+A+M) conjugated to 
alkaline phosphatase (1/4000 dilution) and washing, the alkaline-phosphatase activity 
was determined by measuring the absorbance at 655 nm after a 1-h incubation with 
Bluephos microwell phosphatase substrate (Kirkegaard and Perry Lab., Gaitherburg, 
MD, USA) at 30oC. 
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Panning of the FliTrix peptide library 
 
Amino acid sequences recognized by the antibodies were determined by using the 
FliTrix peptide library system (Invitrogen) according to the manufacturer’s 
recommendation.  Briefly, an aliquot of the amplified FliTrix peptide library (2x1010 
cfu) carrying randomized 12-amino acid sequences was screened by panning with 
anti-hHsp90 mAbs (20 mg/ml in 6-cm dish, Nalge Nunc Int., Roskilde, Denmark) or 
affinity-purified anti-EcHtpG-N pAb (40 mg/ml).  Following 5 cycles of panning, 
selected bacteria were plated on RMG plates containing 0.1 mg/ml ampicillin.  After 
induction of protein expression of the bacteria in IMC medium containing 0.1 mg/ml 
tryptophan for 6 h at 37oC, positive clones were selected by immunoblotting of bacterial 
lysates with respective antibodies used for panning.  Finally, the 12-amino acid 
sequences of the clones that were reactive with the antibodies were deduced by DNA 
sequencing. 
 
Extraction of Hsp90-family proteins from tissues and cells 
 
Tissue extracts of male Wistar rat liver and leaves of rice Oryza sativa var. Taichung65 
at seedling stage, an extract of Paramecium caudatum strain RB1 prepared as reported 
previously (Hirabayashi et al 1983), and cell pellets of budding yeast Saccharomyces 
cerevisiae W303-1A and fission yeast Schizosaccharomyces pombe 972h- were each 
mixed with 3 volumes of SDS-sample buffer containing 8 M urea.  After boiling for 5 
min, aliquots (10 ml) were subjected to immunoblotting.  
 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
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Electrophoresis was performed in the presence of 0.1% SDS at a polyacrylamide 
concentration of 11% or 12.5%.  Generally, 0.25-0.5 mg of purified proteins or 5 ml of 
lysates was loaded onto an SDS-PAGE gel.  Separated proteins were stained with 
Coomassie brilliant blue or subjected to immunoblotting as reported previously 
(Nemoto et al 1997).  Low-molecular-weight markers (Amersham Biosciences) and 
kaleidoscope prestained standards (Bio-Rad) were used as references for proteins 




Purified proteins or bacterial lysates containing recombinant proteins separated on 
SDS-PAGE gels were subjected to immunoblotting analysis as described previously 
(Nemoto et al 1997).  Tissue and cellular extracts of rat liver, budding yeast, fission 
yeast, rice and Paramecium were prepared as reported previously (Hirabayashi et al 
1983).  First antibodies were used at 1-2 mg/ml for blotting of Hsp90 and at 4-8 mg/ml 
for panning clones in 0.1 M Tris-HCl, pH 7.5, containing 0.15 M NaCl, 0.05 % (v/v) 
each of Triton X100 and Tween20 (TBS-TX).  Alkaline phosphatase-conjugated rabbit 
anti-mouse Ig(G+A+M) IgG was used as the second antibody at 0.2 mg/ml in 10 ml 
TBS-TX.  Blots were finally visualized by incubation with 5-bromo-4-chloro-3-indolyl 





Protein concentrations were determined by the bicinchoninic acid method using bovine 




Reactivity of anti-hHsp90 mAbs with the members of the Hsp90 family 
 
Recently, the specificity of the anti-Hsp90 mAbs, which we developed against either 
hHsp90a or hHsp90b, has been characterized systematically with 7 recombinant 
Hsp90-family proteins, i.e., hHsp90a, hHsp90b, hGrp94, hTrap1, yHsc82, EcHtpG, and 
PgHtpG (Kawano et al 2004).    Based on the binding profiles, we classified the 19 
mAbs that could react with both of hHsp90a and hHsp90b into 4 categories: 4 mAbs 
that could blot hHsp90a, hHsp90b, and yHsc82, apparently with similar intensities; 5 
mAbs that reacted with hHsp90s intensively and yHsc82 with a lesser intensity; 9 mAbs 
that reacted with hHsp90a and hHsp90b, but scarcely blotted other members; and 
finally, K3729, which could react with hGrp94 as well as with hHsp90a and 
hHsp90b (Kawano et al 2004). 
Among the 9 mAbs that could blot yHsc82, 5 of them recognized site Ic and all of the 
4 mAbs that blotted yHsc82 and hHsp90 with similar intensities recognized site Ic 
(mAbs with underlines in Fig. 1).  To determine their binding affinities quantitatively, 
we performed ELISA with purified proteins as antigens (Fig. 2a).  The bindings of 
K41110 and K41116C to yHsc82 were identical to those for hHsp90s (Fig. 2a).  The 
binding affinities of K41122B and K41220 for yHsc82 were 1/30 and 1/3, respectively, 
of those for hHsp90s.  Thus, the 8 anti-site-Ic mAbs were tentatively classified into 3 
groups with respect to their binding to yHsc82: Group 1, 2 mAbs (K41110 and 
K41116C) bound to yHsc82 with the affinity identical to that for hHsp90s; Group 2, 3 
mAbs (K41122B, K41220, and K41322) bound to yHsc82 with affinity lower than that 
for hHsp90s; and Group 3, 3 mAbs (K3720, K41331, and K41338) that did not bind to 
yHsc82.  On the other hand, there were 4 mAbs (K3738, K41315, K41016, and 
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K41002) that could interact with yHsc82 and recognized the sites distinct from site Ic 
(Fig. 1).  They recognized the sites distinct to each other, and therefore, they were not 
further characterized. 
Considering the sequence similarity in site Ic between yHsc82 and hHsp90 (see 
Table 8), the reactivity of the anti-site Ic mAbs to yHsc82 was not surprising.  
Inversely, it is curious that the 8 anti-site-Ic mAbs bore a variety of reactivity toward 
yHsc82 from the potent binding of Group-1 mAbs to no binding of Group-3 mAbs.  
We will further investigate the reason for this later. 
We also performed ELISA with K3729, which was the mAb solely reacted with 
hGrp94.  It preferentially bound to hHsp90b over hHsp90a (Fig. 2b).  Its binding 
affinity for hGrp94 was one-third of that for hHsp90b, but was still 3-fold higher than 
that for hHsp90a.  Consistent with the results of the immunoblotting, K3729 did not 
react with other Hsp90-family members (Fig. 2b). 
 
Essential amino acids constituting site Ia 
 
We performed panning experiments using the FliTrix peptide library and anti-hHsp90 
mAbs.  We subjected 30 mAbs to the panning(indicated by marks attached to the 
names of mAbs in Fig 1).  As a result, amino acids important for recognition were 
determined for 14 mAbs (indicated by asterisks); immunologically positive clones were 
not obtained for 9 mAbs (indicated by “-“); and immunologically positive clones were 
obtained for 7 mAbs, but they did not possess consensus sequences (indicated by “+”) 
(see Tables 1, 2, 4-7).  The epitope of 1 mAb (K41007) determined by use of a phage 
display system was reported previously (Nemoto et al 1997). 
We first determined the amino acids essential for the immunogenicity of the anti-site 
Ia mAbs, i.e., K41102, K41116A, K41122A, and K41320 (Table 1).  Because 
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K4000-series mAbs were derived from mice immunized with hHsp90a, the epitope 
sequences were homologous to the sequence of hHsp90a.  In particular, 
Glu251-Ser-X-Asp254 appeared to be important for the recognition.  Even if amino acids 
were substituted: Glu251 was replaced by charged amino acids (Arg with K41102, #1 
and Asp with K41102, #3).  Ser252 was replaced by Gln in one clone (K41320, #2).  
Asp254 was replaced by amino acids with similar properties, i.e., charged amino acid 
(Arg) and Asn. 
 
Essential amino acids constituting site Ib 
 
Five mAbs, K41241, K41315, K41020, K41107, and K41233 recognized the 
immunogenic site Ib, Ser263-Asp-Glu-Glu-Glu-Glu-Lys-Lys270 (Nemoto et al 1997).  
The panning with K41020, K41107, and K41233 produced positive clones on 
immunoblotting, but amino acid sequences were not homologous to each other or to the 
sequence of site Ib (data not shown).  The panning with the mAbs K41241 and 
K41315 failed to result in positive clones on immunoblotting. 
 
Essential amino acids constituting site Ic 
 
The presence of 8 anti-site Ic mAbs categorized as having a variety of bindings to 
yHsc82 (Fig. 2a and data not shown) strongly indicated the differential requirement of 
amino acids for their bindings.  In order to evaluate it, we performed the panning of 
the peptide library by use of the mAbs with two typical binding characteristics to site Ic, 
i.e., K41110 and K41116C (Group-1 mAbs), which bound to site Ic with high affinity; 
and K3720, K41331, and K41338 (Group 3), which did not bind to it.  As a result, we 
obtained 17 clones that interacted with 5 anti-site-Ic mAbs (Table 2).  Among them, 15 
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dodecapeptides were aligned along with the sequence of site Ic without ambiguity.  
One clone (K41110, #3) could be reasonably aligned if a deletion was introduced.  The 
alignment of the clone (K41116C, #2) was less confirmative, because there was little 
homology.  However, the alignment seems to be reasonable if consider the chemical 
characteristics of the 5 amino acids, i.e., Thr-Met-Trp-Ser-Gly (Table 2, K41116C, #2) 
to refer to Pro295-Ile-Trp-Thr-Arg299 (site Ic), as discussed in the following paragraphs. 
Table 2 shows that the region of site Ic defined in the previous study (Asn291-Ile304) 
should be narrowed into 5 amino acids, i.e., Pro295-Arg299.  The frequencies of 
respective amino acids appearing in the positive clones are summarized in Table 3.  
Trp297 was the sole amino acid appearing in all clones.  Thereafter, Pro295 (76%) and 
Arg299 (47 %) were observed; Ile296 was observed at 35% frequency; and finally, Thr298 
at 24%.  Among the selected clones, Pro295, Trp297, and Arg299 existed simultaneously 
in 5 clones (29%).  The combination of Pro295 with Trp297 was found at 47% and that of 
Arg299 with Trp297 was 18%.  Taken together, Trp297 with Pro295 and/or Arg299 was 
present at 94%.  
Table 3 further indicates the amino acids permissible at positions of Ile296 and Thr298.  
At the position of Thr298, Ala or Ser with properties similar to those of Thr was 
occasionally found.  Thus, the percentage when Thr, Ala, or Ser was located at the 
position was 76% (Table 3).  Similarly, in 7 clones (35%), hydrophobic amino acids, 
such as Val (5 clones), Ala (1 clone), Trp (1 clone), and Met (1 clone), were found at 
position 296.  Hence, the percentage when Ile or other hydrophobic amino acids were 
located at the position of Ile296 was 82%. 
Finally, Table 3 highlights the difference in amino acid preference between Group-1 
and Group-3 mAbs.  The frequencies of 5 amino acids emerging in the clones selected 
with Group-3 mAbs were always higher than those selected with Group-1 mAbs.  In 
particular, it was noticeable that Ile296 was observed only in one clone (14%) reactive 
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against Group-1 mAbs, and in 5 clones (50%) against Group-3 mAbs.  Thr298 was 
found in 1 clone (14%) against Group-1 mAbs, and in 3 clones (30%) against Group-3 
mAbs.  In contrast, the frequencies of Arg299 and Pro295 were comparable between the 
clones selected with the 2-group mAbs (Table 3).  These findings strongly suggest that 
Ile296 and Thr298 are closely related to the specificity of anti-site-Ic mAbs.  In fact, 
among the 5 amino acids of site Ic, Ile296 is replaced by Leu in yHsc82 (see Table 8), 
which reasonably explains the specificity of the anti-site-Ic mAbs.  So, the substitution 
of Asp302 of hHsp90 to Ser in yHsc82 was not related to the binding of anti-site Ic 
mAbs. 
 
Essential amino acids constituting site II 
 
We estimated amino acids important for the recognition of anti-site II mAbs.  As 
shown in Table 4, K41007 recognized Ala705-Asp-Asp-Thr-Ser709 of hHsp90a (Nemoto 
et al 1997); K3705, Asp693-Glu-Val-Pro-Ala697 of hHsp90b; and K3725, 
Pro705-Asp-Glu-Ile-Pro709 of hHsp90b.  Reflecting amino acids of site II altered 
between hHsp90a and hHsp90b, the sequences recognized by the mAbs resembled 
either one or the other hHsp90 isoforms (Table 4).  Noticeably, distinct segments 
within site II were recognized by the mAbs.  Thus, we concluded that sites Ia and Ic 
each, formed a single epitope, whereas site II was composed of several epitopes. 
 
Amino acids essential for K3729 
 
We were interested in K3729, because it cross-reacted with hGrp94 (Fig. 2b).  Its 
epitope had remained ambiguous, because it bound to 4 separate sites at residues 
212-312 of hHsp90a, i.e., residues 227-238, 258-270, 282-291, and 301-310 [see Table 
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5, hHsp90a (1)-(4) and Ref 11].  Hence, we performed panning with K3729. 
Although there were 4 potential epitope sites for K3729, it was precisely defined 
from 1 clone (Table 5, #1), which carried the sequence identical to 
Glu222-X-X-X-Ser-Asp-Asp-Glu-Ala-Glu231 (E222XXXSDDEAE231) of 
hHsp90b (equivalent to Asp227-Glu236 of hHsp90a).  Taking other clones into 
consideration, we propose that Ser226-Asp-Asp-Glu229 is the most important, in which 
Asp227 and Glu229 are indispensable.  Ser226 could be substituted by Thr, another amino 
acid harboring a hydroxyl group or charged amino acids, such as Asp and His.  
Noticeably, Glu222 and Ile225 of hHsp90b, which are the amino acids altered between the 
hHsp90 isoforms, were mimicked in clones #1 and #2, respectively.  Taking the 
preferential binding of K3729 to hHsp90b in mind, these amino acids should 
additionally contribute to the binding of K3729.   
This assignment gave an answer as to why K3729 bound to 4 separate regions of 
hHsp90a in an earlier study (Nemoto et al 1997).  Table 5 indicated that one (residues 
227-238) of the 4 peptides corresponded to the true epitope of the mAb [hHsp90a(1)] 
but that the remaining ones [hHsp90a(2)-(4)] possessed similar sequences, i.e., 
Ser231-Asp-(Glu)-Glu234, Asp286-(Gln)-Glu288, or Asp301-Asp-(Ile303).  Because we used 
a multi-pin peptide library covering amino acids 212-312 derived from hHsp90a 
(Nemoto et al 1997), the binding to the hHsp90a peptide was weaker that that to 
hHsp90b.  Under the conditions used, the bindings to these 3 non-epitope sites 
[hHsp90a(2)-(4)] were overestimated. 
This assignment also solved the question of why K3729 was capable of interacting 
with hGrp94 with an affinity higher than that for hHsp90a.  hGrp94 possesses a 
sequence similar to the epitope of hHsp90b, and moreover, the sequence carries Glu291, 
which is equivalent to Glu222 of hHsp90b (Table 5, underlined).  Note that Glu222 of 
hHsp90b was partly involved in the binding of K3729 (Table 5, #1) and was altered to 
 18 
Asp227 in hHsp90a.   
 
Amino acids essential for K41218 
 
The recognition site of K41218, which had been proved to exist within amino acids 
48-196 (Nemoto et al 1997), was precisely determined to be 
Asp71-Ser-Gly-X-Glu-Leu76, in which Gly73 and Glu75 seemed to be essential and Asp71 
and Leu76 were important (Table 6).  Additionally, Leu70 and Ile78 may contribute to 
the binding.   
 
Amino acids essential for K41002 
 
The recognition site of K41002, which had been proved to exist within amino acids 
290-312 (Nemoto et al 1997), was determined.  As shown in Table 7, 
Gly310-Glu-Phe-X-Lys-Ser315 was recognized by K41002.  Charged amino acids, such 
as Arg and Asp, could be located at the position of Lys314.  The region defined in the 
present study (residues 310-315) is slightly shifted from the previous one (residues 
290-312).  However, this is inevitable, because we had defined the region by use of 
various truncated forms and the mAb could interact with hHsp90a 290-312 (Nemoto et 
al 1997).  
 
Effect of the substitution of amino acids constituting site Ic 
 
In order to evaluate the roles of the respective amino acids constituting site Ic, we 
expressed hHsp90a-N with mutated amino acids.  When compared with the sequences 
corresponding to site Ic of eukaryotic Hsp90, Ile296 is substituted to Leu in Candida 
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albicans (Swoboda et al 1995), yHsc82 (Borkovich et al 1989), and heat-inducible 
Hsp82 (Farrelly and Finkelstein 1984) in budding yeast S. cerevisiae (Table 8).  In 
plant cytoplasmic Hsp90, Thr298 is substituted to Met in bread wheat Triticum aestivum 
(NCBI accession, X98582) or to Leu in rice Oryza sativa (japonica cultivar group) 
(AB111810).  In Tetrahymena thermophilia (AF151114) and Toxoplasma gondii 
(A344115), a double substitution to Leu296 and Met298 occurs.  In a plastid-specific 
form of Hsp90, Thr298 is replaced by Met in Secale cereale (Schmitz et al 1996) and the 
double substitution to Leu296 and Met298 occurs in Arabidopsis thaliana (Milioni and 
Hatzopoulos 1997).  In Paramecium tetraurelia (Frankel et al 2001), the substitution 
occurs simultaneously at 3 positions (Leu296, Met298, and Lys299).  With these 
substitutions in mind, we expressed hHsp90a-N with the mutations of Trp297Gly, 
Thr298Met, Ile296Leu/Thr298Met, and Arg299Gly.  The recombinant proteins were 
purified by affinity chromatography (Fig. 4a).  hHsp90a Arg299Gly appeared to be 
partially degraded (lane 5).   
We first analyzed the bindings of anti-site-Ic mAbs to the mutants at positions 296, 
297, and 298.  As a positive control, we evaluated the binding of K41102, which 
recognized site Ia (Table 1).  The mAb equivalently bound to hHsp90a-N irrespective 
of the substitutions (Fig. 3b).  In contrast, the bindings of the anti-site Ic mAbs were 
drastically altered by the substitutions:  None of the 8 mAbs bound to Trp297Gly even 
at the highest antibody concentration used (Fig. 3c-e).  This finding faithfully reflected 
the appearance of Trp297 in all clones selected by panning (Table 2).  In contrast, the 
bindings for Thr298Met and Ile296Leu/Thr298Met were dependent on the mAbs:  The 
bindings of Group-1 mAbs to Thr298Met were scarcely affected (Fig. 4c); but the 
binding affinities for Thr298Met of the remaining 6 anti-site-Ic mAbs except for 
K41338 were decreased at least to one-third of those for the wild type.  An additional 
substitution of Ile296 to Leu further decreased the binding affinities for anti-site Ic mAbs, 
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but the effect was little for Group-1 mAbs (Fig. 3c).  Similarly, the effect was 
relatively small on 2 Group-2 mAbs (K41220 and K41322; Fig. 3d), but 1 Group-2 
mAb (K41122B) and 2 Group-3 mAbs (K3720 and K41331) showed a significant 
reduction (<1/300) in binding affinity.  The remaining Group-1 mAb (K41338) did not 
bind to the double mutant under the conditions employed (Fig. 3e).  Therefore, we 
concluded that the binding affinities of Group-1 mAbs for the double mutant 
Ile296Leu/Thr298Met were slightly decreased (1/3 – 1/2) but that those of the 
remaining 6 mAbs were significantly reduced at least to one-tenth.  In particular, the 
substitution of Ile296 to Leu significantly reduced the binding affinities of Group-3 
mAbs.  With these data taken together, we conclude that Ile296 and Thr298 were 
important for Group-3 mAbs (with the exception of K41338 for Thr298), but were not 
critical for the recognition of Group-1 mAbs. 
We then evaluated the effect of the substitution of Arg299 to Gly.  The change 
slightly and reduced 10-fold, respectively, the bindings of K41116C and K41110 (Fig. 
5b), and caused a significant reduction (<1/30) in those of the remaining 6 anti-site-Ic 
mAbs (Fig. 3c and d):  Especially, K3720 never bound to Arg299Gly even at the 
highest antibody concentration (Fig. 3c).  Thus, although Arg299 was one of the 
important determinants of site Ic for most anti-site-Ic mAbs, the effect was little on the 
Group-1 mAbs.  In contrast, the mutation did not affect the binding of mAbs that 
recognized the sites other than site Ic (data not shown). 
We also performed immunoblotting analysis. Group-1 mAbs could blot Thr298Met, 
Ile296Leu/Thr298Met, and Arg299Gly, but scarcely blotted Trp297Gly (Fig. 3a), in 
consistent to the results of ELISA (Fig. 3b and c). 
Although we did not perform the mutation of Pro295, this amino acid appeared to be 
important for antibody recognition, because: (i) the frequency (76%) of Pro295 appearing 
in the selected clones was higher than the 47% of Arg299 (Table 3); and (ii) EcHtpG, in 
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which Pro295-Ile-Trp-Thr-Arg299 of eukaryotic Hsp90 is converted to 
Ala-Leu-Trp-Thr-Arg (Table 8), was not recognized by any site-Ic mAb. 
 
Immunogenicity of the region corresponding to site Ic of EcHtpG 
 
Although the sequences corresponding to site Ic of hTrap1, EcHtpG, and PgHtpG were 
partially homologous to that of hHsp90 (Table 8), none of the anti-site-Ic mAbs bound 
to them (Fig. 2a and data not shown).  In view of the findings obtained by mutagenesis 
(Figs. 3 and 4), either one of Pro295 or Arg299 replaced in these 3 proteins should explain 
this phenomenon:  Pro295 is replaced by Ala in EcHtpG and hTrap1; and Arg299 is 
replaced by Lys in PgHtpG.  Alteration of Ile296 to Leu in EcHtpG and to Ala in 
PgHtpG, and that of Thr298 to Met in hTrap1, may additionally contribute to the 
phenomenon.  On the other hand, these facts raised a new question:  Is the region of 
other Hsp90-family members equivalent to site Ic of hHsp90 immunogenic? or is the 
triplet of Pro295, Trp297, and Arg299 essential for this role?  To address this issue, we 
chose EcHtpG, which carries Ala at the position of Pro295 (Table 9).  We performed 
panning of the peptide library with the pAb raised and purified with EcHtpG-N.   
After 5 cycles of panning, all clones were positive on immunoblotting with the pAb.  
Then, we randomly selected 7 clones and sequenced the oligonucleotides of 36 bases.  
Among 7 clones, 5 clones (Table 9, #1-5) possessed 2 or 3 amino acids matching the 
site-Ic sequence of EcHtpG.  Three clones (#2, #4, and #5) could be aligned in 2 ways.  
Interestingly, at the position of Arg236 of EcHtpG, equivalent to Arg299 of hHsp90a, 
charged amino acids (Lys and Glu) were located in 3 clones [#1, #2(1), and #5(2)].  On 
the other hand, the amino acids of both #6 and #7 were not similar to the site-Ic 
sequence, but they appeared to be partially homologous to a single site, Ile36-Leu46 
(Table 9).  So, we conclude that the site of EcHtpG equivalent to site Ic of hHsp90a is 
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also immunogenic even though the sequence carries Ala at the position of Pro295.  In 
the 7 selected clones, we did not detect Trp at position 297.  We do not know the 
reason for this at present. 
 
Immunoblotting analysis of Hsp90 endogenously expressed in various species 
 
The findings in Figs. 2b and 3c prompted us to examine the reactivity of Group-1 mAbs 
to endogenous forms of eukaryotic Hsp90-family members (Table 8, lower 4 species).  
K41110 and K41116C specifically recognized 80-90-kDa species from rat liver, 
budding yeast (S. cerevisiae), fission yeast (Schizosaccharomyces pombe) (Aligue et al 
1994), rice (Oryza sativa, AB111810), and Paramecium caudatum (Fig. 5).  To the 
contrary, K41220, which belonged to Group 2, did not bind to P. caudatum Hsp90 (lane 
5) and scarcely bound to rice Hsp90 (lane 4).  We also tested an anti-Hsp90 mAb 
AC88, which has been reported to react with Hsp90 from various species (Riehl et al 
1985).  Although it was developed against eukaryotic filamentous fungi Achlya 
ambisexualis, it efficiently recognized rat Hsp90 as previously reported (Chen et al 
1997).  It blotted P. caudatum Hsp90 as a faint band, and did not detect Hsp90 from 




Recently we characterized the immunological cross-reactivity of the members of the 
Hsp90 family with a number of anti-hHsp90 mAbs.  In combination with ELISA in the 
present study, we concluded that 2 mAbs reacted with yHsc82 with affinity identical to 
that for hHsp90, and 7 mAbs reacted with yHsc82 with affinities lower that that for 
hHsp90.  Also, one reacted with hGrp94 with a moderate affinity.  In the present 
study, we identified essential amino acids constituting various epitopes of hHsp90a and 
hHsp90b.  In particular, 3 of the 4 highly immunogenic sites reported previously were 
further characterized in this study.  As a result, we demonstrated that sites Ia and Ic 
each formed a single epitope, but showed that site II was composed of several epitopes.  
We could not define the amino acids essential for site Ib. 
Among 11 amino acids constituting site Ia reported previously (Nemoto et al 1997), 
Glu251-Ser-X-Asp254 of hHsp90a was most important for the recognition by the mAbs 
(Table 1).  On the other hand, among 14 amino acids (Asn291-Ile304) of site Ic (Nemoto 
et al 1997), only 5 residues from Pro295 to Arg299 were required for the antibody 
recognition.  The observations in this study indicate that the immunogenicity of 
Glu222-Ala230 in hHsp90b is shared by Glu281-Ala289 of hGrp94 and that that of site Ic in 
hHsp90 is shared by yHsc82. 
The finding that hGrp94 shared immunogenicity with hHsp90b at the epitope for 
K3729 (Table 5) suggests the usefulness of this mAb for the detection of hGrp94.  
However, usefulness of K3729 for detection of Grp94 may be limited to mammals, 
because the sequence is conserved in mouse (Mazzarella and Green 1987), bovine 
(AB025193), pig (de Crom et al 1999) Grp94, but is altered in chick (Kulomaa et al 
1986), barley (Walther-Larsen et al 1993), and Arabidodopsis thaliana (Ishiguro et al 
2002). 
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Among 9 mAbs that reacted with yHsc82, 5 mAbs recognized site Ic.  This may not 
be surprising in consideration of the sequence homology of site Ic (Table 8).  However, 
it seems important to note that, among 8 anti-site-Ic mAbs, there were 3 anti-site-Ic 
mAbs that did not react with yHsc82.  Among the 5 amino acids constituting the 
epitope of site Ic, Trp297 was essential; and Pro295 also appeared to be essential.  The 
frequency of Arg299 appeared in the panning clones followed that of Pro295:  Arg299 was 
important for most site-Ic mAbs, but not essential for the immunoreactivity, because the 
mutant with Arg299Gly possessed potent reactivity toward 7 of the 8 anti-site-Ic mAbs 
(Fig. 4).  Moreover, K41116C showed the binding to Arg299Gly comparable to that for 
an intact form and K41110 had considerable binding ability. 
The frequencies of Ile296 and Thr298 that emerged in the panning clones were lower 
than that frequency of Arg299.  In fact, these 2 amino acids were less critical than Pro295, 
Trp297, and Arg299 were for the 2 Group-1 mAbs.  It was not surprising that Group-1 
mAbs did not require Ile296, because we classified anti-site-Ic mAbs based on the 
reactivity to yHsc82, which carries Leu at position 296.  However, it was noticeable 
that the 2 mAbs tolerated the substitution of Thr298 to Met. 
The 5 amino acids of site Ic are completely conserved in most eukaryotic Hsp90s, 
such as those of mammals (Hickey et al 1989; Rebbe et al 1987; Moore et al 1989; 
Huang et al 1999), chick (Binart et al 1989; Meng et al 1993), fission yeast S. pombe 
(Aligue et al 1994), nematoda Caenorhabditis elegans (Massie et al 2003), and 
Drosophila melanogaster (Helmgren et al 1981).  Moreover, Pro295 and Trp297 are 
completely conserved and Arg299 is highly conserved in eukaryotic Hsp90s. 
The in vitro mutagenesis experiment combined with the immunoblotting analysis and 
ELISA demonstrated that K41110 and K41116C could interact with 
Pro295-Ile(Leu)296-Trp297-Thr(Met)298-Arg(Gly)299.  Rice Hsp90, which was recognized 
by the mAbs (Fig. 5), carries Leu instead of Thr298, which further indicates that Leu at 
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position 298 could be blotted with the mAbs.  Arg299 was also one of the important 
determinants for most of the anti-site-Ic mAbs.  However, one of the Group-1 mAbs 
(K41116C) did not discriminate Arg299Gly from hHsp90a-N (wild type); and another 
(K41110) also bound to Arg299Gly, although the binding affinity was decreased to 
one-tenth.  Actually, they could blot P. caudatum Hsp90 (Fig. 5), which potentially 
possesses Arg299, as does P. tetraurelia Hsp90.  Therefore, we conclude that anti-site Ic 
mAbs that belong to Group 1 recognize all eukaryotic Hsp90s.  
The sequences of site Ic of hGrp94, hTrap1, EcHtpG, and PgHtpG are partially 
homologous to that sequence of hHsp90 (Table 7), but none of them were blotted with 
anti-site-Ic mAbs (Fig. 2b).  Nevertheless, the binding affinities for the 4 recombinant 
proteins could be estimated by ELISA at higher antibody concentrations (Fig. 2a).  
PgHtpG could be partially recognized by Group-1 mAbs and K41122B (Fig. 2b).  In 
contrast, hGrp94 was never recognized by Group-1 mAbs and was second least 
efficiently recognized by K41122B next to hTrap1 (Fig. 2b).  The site-Ic sequence of 
PgHtpG is Pro-Ala-Trp-Thr-Lys, of which Ile296 and Arg299 are substituted to Ala and 
Lys, respectively.  Thus, the change of Arg299 to Lys may primarily cause the loss of 
the binding.  However, as we demonstrated in Figs. 5 and 6, the change of Arg299 had 
little effect on Group-1 mAbs, especially on K41116C.  In view of this finding, we 
postulate that the second substitution of Ile296 to Ala additionally abrogated the binding.  
It may be not surprising that the change of Ile296 to Ala caused a more profound effect 
on the antibody binding than the change of Ile296 with respect to Leu on Group-1 mAbs. 
Among the 7 recombinant proteins, hGrp94 was least efficiently bound by Group-1 
mAbs on ELISA (Fig. 2b).  However, the Pro295, Trp297, and Arg299 triplet and Ile296 as 
well is maintained in hGrp94 (Table 8).  What does this apparent discrepancy imply?  
The sole amino acid substitution from Thr298 to Gln should be responsible for this 
phenomenon, for Gln located at the position of Thr298 prevented the antibody binding in 
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a dominant-negative manner.  In order to address this issue, we compared the amino 
acids located at the position of Thr298.  Thr is located at position 298 in EcHtpG and 
PgHtpG identical to hHsp90a; and Met is present in hTrap1 (Table 8).  In the panning 
experiment, Thr (4 clones), Ala (6 clones), and Ser (3 clones) were occasionally 
recovered; and each of Met, Leu, Val, and Asp, respectively, emerged in 1 clone (Table 
2), which strongly suggests that Met and Leu were permitted to be located at this 
position but that Gln298 sterically interfered with the antibody binding.  If this is true, 
inversely, the antibody raised against site Ic of hGrp94 would be expected to interact 
with hHsp90.  In fact, we found that antibodies raised against site Ic of hGrp94 could 
interact with hHsp90s, although the affinity was decreased to one-tenth (Kawano et al 
2004).  This discussion concerning Ala at the position of Ile296 and Gln at the position 
Thr298 implies that Ile296 and Thr298 are also important for the recognition by Group-1 
mAbs as well as by Group-3 mAbs, but that, principally, Group-1 mAbs less stringently 
recognize Ile296, Thr298, and Arg300 for their recognition than do Group-3 mAbs. 
We propose that K41110 and K41116C can be used as potent tools for detecting all 
eukaryotic Hsp90.  Historically, AC88/SPA830 has been used for the analysis of 
Hsp90, because it was the first-developed anti-Hsp90 mAb and interacts with Hsp90 
from various species with the 2 isoforms of mammalian Hsp90 (Riehl et al 1985).  
However, its reactivity was limited in some groups of eukaryotes (Fig. 5 and Kawano et 
al 2004).  Thus, although the contribution of AC88 in the previous studies should be 
admitted, K41110 and K41116C should be superior to AC88 for detection of eukaryotic 
Hsp90.  Interestingly, Grp94 of some species, such as trypanozoma Leishmania 
infantum (Larreta et al 2000) and sea urchin Strongylocentrotus purpuratus (Smith et al 
1996), possesses the sequence Pro-Ile-Trp-Thr-Arg identical to site Ic of hHsp90.  
Hence, Grp94 from these species could be recognized by all anti-site-Ic mAbs. 
It was reported that antibodies against Hsp70 and Hsp90 were produced in patients 
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with lupus erythematosus (Minota et al 1988; Twomey et al 1993).  It is important to 
evaluate whether HtpG of P. gingivalis as well as that of Actinobacillus 
actinomycetemcomitans, another implicated pathogen, is truly involved in the 
autoimmune responses in those patients.  However, we demonstrated that, on 
immunoblotting analysis, 19 anti-hHsp90 mAbs tested could not recognize PgHtpG or 
EcHtpG even when they were anti-site Ic.  Therefore, we suppose that that, even if 
antibodies against hHsp90 are produced in periodontitis, the antigen is unlikely to be 
derived from bacteria but rather is hHsp90 of host cells. 
As clearly demonstrated in the present study, panning method of FliTrx peptide 
library is a powerful tool for determining the epitopes of mAbs.  Moreover, this study 
further demonstrated that pAbs can be used for this technique.  Serially truncated 
proteins and peptides produced by recombinant techniques, which are conventionally 
used for the identification of epitopes, could be substituted by this approach.   
In addition to sites Ia and Ic, we defined essential amino acids of several anti-Hsp90 
mAbs:  K3705 recognized Asp693-Ala697 of hHsp90b (Table 4); K3725B recognized 
Pro705-Pro709 of hHsp90b (Table 4); K3729 primarily recognized Ser226-Glu231 of 
hHsp90b (Table 5); K41218 recognized Asp71-Leu76 (Table 6); and K41002 recognized 
Gly310-Ser315 (Table 7).  The information on the epitopes of these mAbs is useful for 
future investigation on the chaperone cycle of Hsp90.   
The 3-dimensional structures of the N-terminal ATP-binding 220/230 amino acids of 
hHsp90 and yHsp82 and the middle domain (residues 273-528) of yHsp82 equivalent to 
residues 293-549 of hHsp90a have been determined (Stebbins et al 1997; Prodromou et 
al 1997a; Meyer et al 2003), which indicates that the 5 amino acids of site Ic form a 
loop exposed outside the domain.  Moreover, we found that anti-site Ic mAbs 
(K41116C and K41220) could adsorb glucocorticoid  receptor-Hsp90 complex from 
rat liver (J. Kishimoto and T. K. Nemoto, unpublished observation), which further 
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indicated that site Ic is exposed to outside of an Hsp90 molecule, and moreover, that site 
Ic is not directly involved in client binding. 
We also mapped the epitope of K41002 (amino acids Gly310-Ser315) on the structure.  
The site formed an a-helix adjacent to site Ic; and the most important amino segment, 
Gly310-Glu-Phe312, was located to the outside of the domain (Prodromou et al 1997a).  
Similarly, the epitope of K41218 was mapped at the surface of the N-terminal domain, 
forming a loop connecting an a-helix and a b-strand structure (Stebbins et al 1997; 
Prodromou et al 1997a).  Other epitopes defined in the present study may also be 
located on the surface of the Hsp90 molecule; however, they could not be mapped at 
present, because they were located in either the highly charged region or in the 
C-terminal region, the 3-dimensional structures of which remain unknown.  Although 
the dimer-forming, C-terminal domain of HtpG of E. coli has been reported recently 
(Harris et al 2004), the C-terminal end of Hsp90 (amino acids 697-732), which carries 
immunogenic site II, can not be pictured yet, because the corresponding region is 
deleted in HtpG. 
We previously reported that, even if residues 289-389 and its adjacent C-terminal 
region, residues 401-546 of hHsp90 were separately expressed, they formed a stable 
complex in vitro and in vivo (Tanaka et al 2001; Matsumoto et al 2002).  With 
reference to the 3-dimensional structure (Meyer et al 2003), the interaction appears to 
be primarily maintained through the association of the 5 b-sheets strands (amino acids 
324-392 in hHsp90a ) and the longest a-helix structure (amino acids 410-428).  We 
further propose as the activation mechanism of Hsp90 molecular chaperone that heat 
stress induces the liberation of the oligomerization/client-binding site of residues 
311-350 by disrupting the intra-molecular interaction between residues 289-389 and 
401-546 (Tanaka et al 2001; Matsumoto et al 2002).  In fact, there are several lines of 
evidence that amino acids 289-389 are involved in client binding:  A binding site of 
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hHsp90b for Ser/Thr kinase Akt/PKB was mapped to amino acids 327-340, equivalent 
to 335-348 of hHsp90a (Sato et al 2000);  It has been proposed that amino acids 
347-360 form a potential client-binding site (Meyer et al 2003).  We recently mapped 
amino acids 311-350 as an essential region for self oligomerization/client binding 
(Nemoto et al 2004).  Moreover, a similar b-sheet platform is involved in client 
binding of DnaK (Zhu et al 1996) and MHC I molecule (Fremont et al 1995).  
Therefore, it is interesting to investigate whether or not the accessibility of the 
antibodies to the 5 b-sheet strands as well as to the a-helix structure is modified coupled 
with the heat-induced activation process of the Hsp90 molecular chaperone.  Such an 
investigation is now under way in our laboratory. 
  Previous studies demonstrated that the presence of antoantibodies to Hsp90 in 
systemic lupus erythematosus (Minota et al 1988).  Although Hsp90 is a cytosolic 
protein, surface expression of Hsp90 on peripheral blood mononuclear cells was found 
in a quarter of the patients with systemic lupus erythematosus during active state 
(Erkeller-Yuksel et at 1992).  The level of Hsp90 has been shown to be elevated in 
peripheral blood mononuclear cells of a subset of systemic lupus erythematosus patients, 
mainly caused by transcription activation of Hsp90b gene (Twomey et al 1993).  
Kenderov et al (2002) proposed that immunopathogenesis of lupus nephritis is 
associated with Hsp90 as an autoantigen and that the pathology is associated with 
altered idiotypic regulation of the anti-Hsp90 IgG autoantibodies.  On the other hand, 
it remains unknown whether or not there are epitopes of Hsp90 specifically involved in 
autoimmune responses.  Thus, it seems important to determine to the epitopes of 
Hsp90, such as those defined in the present study, are involved in responses of 
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 FIGURE LEGENDS 
 
Fig. 1. Epitope map of the mAbs developed against hHsp90a or hHsp90b - Recognition 
sites of 33 anti-hHsp90 mAbs are represented along with the 732 amino acid hHsp90a.  
N, M, and C represent N-terminal, middle, and C-terminal domains, respectively 
(Nemoto et al 1997).  The hatched box (residues 223-289) represents highly charged 
region localized in the N-terminal domain.  Isoform specificity of mAbs except for 
K3725A is indicated by their letters as follows: bold, hHsp90a specific; not modified, 
hHsp90a preferential; bold italic, hHsp90b specific; italic, hHsp90b preferential; and 
underlined, bound to both isoforms equivalently.  The recognition sites of mAbs were 
identified as epitopes (indicated by boxes) or regions carrying the epitopes (indicated by 
bars).  Highly immunogenic regions, sites Ia, Ib, Ic, and II correspond to residues 
247-257, 263-270, 291-304, and 702-716, respectively.  Thirty mAbs were tested for 
panning as described in “MATERIALS AND METHODS”:  Amino acids responsible 
for the recognition were identified for 14 mAbs (indicated by *);  Nine mAbs did not 
yield positive clones on immunoblotting (-);  Seven mAbs yielded clones positive on 
immunoblotting, but the sequences they recognized either resembled each other nor 
matched the sequence of hHsp90s (+).  Two mAbs without marks were not subjected 
to the panning.  aprecisely defined by the panning experiment in this study (see Tables 
5-8).  bdetermined by phage display system in a previous study (Nemoto et al 1997 and 
see Table 4). 
 
Fig. 2. ELISA of mAbs that could interact with yHsc82 or hGrp94 - (a) Bindings of the 
4 mAbs that could blot yHsc82 as intensively-stained bands were quantified by ELISA.  
(b) The binding of K3729 was quantified by ELISA.  Symbols for the 7 Hsp90-family 
proteins are the following: hHsp90a (open circle); hHsp90b (closed circle); hGrp94 
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(open square); hTrap1 (closed square); yHsc82 (open triangle); EcHtpG (closed 
triangle); and PgHtpG (closed inverted triangle). 
 
Fig. 3. Effect of mutation at Ile296, Trp297, Thr298, and Arg299 on the antibody binding – 
(a) Aliquots of purified hHsp90a-N wt (lane 1), Trp297Gly (lane 2), Thr298Met (lane 
3), Ile296Leu/Thr298Met (lane 4), and Arg299Gly (lane 5) were separated on 
SDS-PAGE and then stained with Coomassie brilliant blue (CBB) or subjected to the 
immunoblotting with K41110 or K41116C.  (b-d) ELISA was performed with 
hHsp90a-N wt (open circle), Trp297Gly (closed circle), Thr298Met (open square), and 
Ile296Leu/Thr298Met (open triangle) as antigens.  Lane M, molecular markers.  
Groups 1-3 were categorized based on the reactivity toward yHsc82 (see “RESULTS”). 
 
Fig. 4.  Effect of the mutation at Arg299 on the antibody binding – ELISA was 
performed with hHsp90a-N wt (open circle) and Arg299Gly (closed circle) as antigens 
by using 8 anti-site-Ic mAbs.  Eight anti-site Ic mAbs were categorized into Groups 1 
(a), 2 (b), and 3 (c) based on the reactivity toward yHsc82. 
 
Fig. 5. Immunoblotting analysis of the Hsp90-family proteins endogenously expressed 
in eukaryotes - Tissue or cell pellets of several species were denatured in SDS-sample 
buffer, and aliquots (5 ml) were loaded onto SDS-PAGE gels.  Separated proteins were 
immunoblotted with K41110, K41116C, K41220 or AC88/SPA-830 (Stressgen).  Lane 
1, rat liver; lane 2, budding yeast (S. cerevisiae); lane 3, fission yeast (S. pombe); lane 4, 
rice (O. sativa) and lane 5, P. caudatum.  Lane M, kaleidoscope prestained standards. 
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Table 1. Epitope mapping with anti-site-Ia mAbs 
                                                                          
hHsp90a          242 E E E K E K E E K E S E D K P E 257 
hHsp90b                236 E K E E E D K D D E E K P 249 
K41102 #1        G P M E I D R S G D V D 
           #2             G G VS A E S L D H A W 
           #3             R Q TE V D S G R D L E 
K41116A   #1           R Q M VE K E S L D Q A  
            #2        R N T W D Y W E S L D V 
K41122A   #1         C G K R A L R E S L N R 
K41320    #1         R P L G L Q E E S L D G 
            #2     G V D G L D L P L E Q L 
                                                                       
Site Ia is underlined.  Amino acids identical to hHsp90a are indicated by bold letters. 
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Table 2. Epitope mapping with anti-site-Ic mAbs 
                                                                                 
hHsp90a           291 N K T K P I W T R N P D D I 304 
hHsp90b           283 N K T K P I W T R N P D D I 296 
Group 1 
K41110   #1       G K L A P T W T R Q S A 
   #2    G D V R F S R V W M R G 
   #3   F V P A E R Y P * W V D Q 
   #4  L V G Q F H T P A W A E 
   #5         T M R P I W A R S G A V 
K41116C  #1     A V L M L P V W A C L S 
   #2   G R N G K Q T M W S G G   
Group 3 
K3720   #1    A A S S R V P I W S R R   
   #2                V W T R A E L I G A F G 
  #3       R G N V P V W T Q R S K 
K41331 #1    Y M R F N T P I W A S T 
  #2      V G A F G P W W S D H S 
  #3   V E S V R A Y P I W A R 
  #4           V T T P P W T A P K S R 
K41338 #1    G G G G D I V P I W A R 
  #2         G R G G A I W D R P E F 
  #3      F M G F S L P V W L D P 
                                                                                     
*deletion.  Site Ic is underlined.  Amino acids identical to hHsp90 are indicated by 
bold letters. 
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Table 3. Amino acids that appeared at the 5 positions of site Ic in selected clones 
           
                Frequency  
Amino acid    Total   Group 1  Group 3   
Pro295    13  (76%) 5  (71 %)  8  (80 %) 
Ile296      6  (35%) 1  (14 %)  5  (50%) 
Ile/Val/Trp/Ala/Met296   14  (82 %) 5  (71 %)  9  (90 %) 
Trp297    17 (100 %) 7  (100 %) 10 (100 %) 
Thr298      4  (24 %) 1  (14 %)   3  (30 %) 
 Thr/Ala/Ser298    13  (76 %) 5  (71 %)  8  (80%) 
Arg299      8  (47 %) 3  (43 %)  5  (50 %) 
 
Total                 17 (100 %)    7 (100 %)      10 (100 %) 
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Table 4. Epitope mapping with anti-site-II mAbs                                                                                
                                                                           
hHsp90a         701 D D P T A D D T S A A V T E E M P P L E G D D D 724 
hHsp90b                693 D E V A A E E P N A A V P D E I  P P L E G D E D 716 
K41007a               W V A * D T S Y 
K3705              D E V P A HV D G E L N 
K3725B    #1                          E P D E V A M E V R M G 
           #2                V S T L I E L P D E I  P 
           #3                             D E I  P E P A V P C G G 
                                                                            
*deletion.  areported in Nemoto et al 1997.  Site II is underlined.  Amino acids 
identical to hHsp90a (K41007) or hHsp90b (K3000 series) are indicated by bold letters.  
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Table 5. Epitope mapping with K3729 
                                                                     
hHsp90a     227 DKEVSDDEAEEKEDKEEEKEKEEKESEDK 255 
hHsp90b     222 EKE I SDDEAEEEKG***EKEEEDKDDEEK 247 
hGrp94     267 TVEEPMEEEEAAKE*****EKEESDDEAAV 291 
yHsc82      215 KEVPIPEEEKKDEEKK****DEDDKKPKLE 240 
K3729  #1      EVAESDDEAEVY 
       #2      EPGLIDDDERNT 
       #3    SPLQGSTDDESA              
       #4         RSDTDDERSESG 
#5    NWGQVESDLEFE 
       #6     SSLSDMHDCESV 
       #7       AGVDTDWEPHGR 
hHsp90a (1)   227 DKEVSDDEAEEK 238 
hHsp90a(2)  258 I EDVGSDEEEEKK 270  
hHsp90a(3)     282 EKIDQEELN 291 
hHsp90a(4)               301 PDDITNEEYG 310 
                                                                     
*deletion.  Amino acids of hHsp90b corresponding to the epitope of K3729 deduced 
from selected clones (#1 - #7) and those of hHsp90a and hGrp94 homologous to the 
epitope sequence of hHsp90b are underlined.  Amino acids of positive clones and 




Table 6. Epitope mapping with K41218 
                                                            
hHsp90a      68 S K L D S * G K E L H I N L I 81 
hHsp90b           63 S K L D S * G K E L K I D I I 76 
K41218   #1     V L D * * G A E L K E R E N 
          #2    A G N Y * G E E L L P V D 
          #3      A L K * G A E L L I H G S 
          #4    R R D S G G F E Q I W G 
          #5      W D S * G F E L S G P G K 
                                                            
*deletion.  Amino acids identical to hHsp90a are indicated by bold letters.  
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Table 7. Epitope mapping with K41002 
                                                        
hHsp90a   306 N E E Y G E F Y K S L T N D W 320 
hHsp90b   298 Q E E Y G E F Y K S L T N D W 312 
K41002 #1        D R G E G P R I N A R C 
       #2     A I M P K E F D K S E W 
       #3          A G E F G D L R R A R A 
                                                        




Table 8. Comparison of site-Ic sequences of Hsp90 from various species 
                                                           
hHsp90a a /hHsp90b a   NKTK PIWTRNPDDI 
hGrp94a    NDI K PIWQRPSKEI 
hTrap1a    NTLQAIWMMDPKDV 
yHsc82 a, b/yHsp82b    NKTK PLWTRNPSDI 
EcHtpGa    NKAQALWTRNKSEI 
PgHtpG a    INDTHPAWTKKPADL 
 
rat Hsp90b     NKTK PIWTRNPDDI 
Schizosaccharomyces pombe Hsp90b NKTK PIWTRNPSEV 
Oryza sativa Hsp90b    NKQK PIWLRKPEEI 
Paramecium tetraurelia Hsp90   NKNK PLWMKKPDDI 
                                                            
aHsp90-family members subjected to the immunoblotting in Fig. 2. 
bHsp90-family members endogenously-expressed in cells subjected to the 
immunoblotting in Fig. 5.  In the last line, the sequence of that of P. tetraurelia Hsp90 
is shown instead of P. caudatam used in this study.  Amino acids identical to those of 





Table 9. Epitope mapping of anti-EcHtpG-N pAbs 
                                                                        
hHsp90a    291 N K T K P I W T R N P D D I 304 
EcHtpG       228 N K A Q A L W T R N K S E I 241 
#1            A G G G A VW N E V D L 
#2(1)          L K A L G L N M E P V P 
#2(2)              L K A L G L N M E P V P 
#3                  I G C I M R N A G T A N 
#4(1)        T L Q A L K G C T R R Y 
#4(2)            T L Q A L K G C T R R Y 
#6(1)                 A L E R K C G A L V E V 
#6(2)    A L E R K C G A L V E V 
 
hHsp90a   59 I S N S S D A L D K I R Y E 62 
EcHtpG    36 I S N A S D A A D K L R F R 49 
#5           I N V T L F V A D N L P 
#7           T E T E V G L R D G L G 
                                                                        
Three clones (#2, #4, and #6) are aligned in 2 ways.  The 5 amino acids essential for 
site Ic are underlined (see Table 2).  Amino acids identical to those of EcHtpG are 





Fig. 1. Epitope map of the mAbs developed against hHsp90a or hHsp90b - Recognition 
sites of 33 anti-hHsp90 mAbs are represented along with the 732 amino acid hHsp90a.  
N, M, and C represent N-terminal, middle, and C-terminal domains, respectively 
(Nemoto et al 1997).  The hatched box (residues 223-289) represents highly charged 
region localized in the N-terminal domain.  Isoform specificity of mAbs except for 
K3725A is indicated by their letters as follows: bold, hHsp90a specific; not modified, 
hHsp90a preferential; bold italic, hHsp90b specific; italic, hHsp90b preferential; and 
underlined, bound to both isoforms equivalently.  The recognition sites of mAbs were 
identified as epitopes (indicated by boxes) or regions carrying the epitopes (indicated by 
bars).  Highly immunogenic regions, sites Ia, Ib, Ic, and II correspond to residues 
247-257, 263-270, 291-304, and 702-716, respectively.  Thirty mAbs were tested for 
panning as described in “MATERIALS AND METHODS”:  Amino acids responsible 
for the recognition were identified for 14 mAbs (indicated by *);  Nine mAbs did not 
yield positive clones on immunoblotting (-);  Seven mAbs yielded clones positive on 
immunoblotting, but the sequences they recognized either resembled each other nor 
matched the sequence of hHsp90s (+).  Two mAbs without marks were not subjected 
to the panning.  aprecisely defined by the panning experiment in this study (see Tables 
5-8).  bdetermined by phage display system in a previous study (Nemoto et al 1997 and 
see Table 4). 
 
Fig. 2. ELISA of mAbs that could interact with yHsc82 or hGrp94 - (a) Bindings of the 
4 mAbs that could blot yHsc82 as intensively-stained bands were quantified by ELISA.  
(b) The binding of K3729 was quantified by ELISA.  Symbols for the 7 Hsp90-family 
proteins are the following: hHsp90a (open circle); hHsp90b (closed circle); hGrp94 
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(open square); hTrap1 (closed square); yHsc82 (open triangle); EcHtpG (closed 
triangle); and PgHtpG (closed inverted triangle). 
 
Fig. 3. Effect of mutation at Ile296, Trp297, Thr298, and Arg299 on the antibody binding – 
(a) Aliquots of purified hHsp90a-N wt (lane 1), Trp297Gly (lane 2), Thr298Met (lane 
3), Ile296Leu/Thr298Met (lane 4), and Arg299Gly (lane 5) were separated on 
SDS-PAGE and then stained with Coomassie brilliant blue (CBB) or subjected to the 
immunoblotting with K41110 or K41116C.  (b-d) ELISA was performed with 
hHsp90a-N wt (open circle), Trp297Gly (closed circle), Thr298Met (open square), and 
Ile296Leu/Thr298Met (open triangle) as antigens.  Lane M, molecular markers.  
Groups 1-3 were categorized based on the reactivity toward yHsc82 (see “RESULTS”). 
 
Fig. 4.  Effect of the mutation at Arg299 on the antibody binding – ELISA was 
performed with hHsp90a-N wt (open circle) and Arg299Gly (closed circle) as antigens 
by using 8 anti-site-Ic mAbs.  Groups 1-3 were categorized based on the reactivity 
toward yHsc82. 
 
Fig. 5. Immunoblotting analysis of the Hsp90-family proteins endogenously expressed 
in eukaryotes - Tissue or cell pellets of several species were denatured in SDS-sample 
buffer, and aliquots (5 ml) were loaded onto SDS-PAGE gels.  Separated proteins were 
immunoblotted with K41110, K41116C, K41220 or AC88/SPA-830 (Stressgen).  Lane 
1, rat liver; lane 2, budding yeast (S. cerevisiae); lane 3, fission yeast (S. pombe); lane 4, 
rice (O. sativa) and lane 5, P. caudatum.  Lane M, kaleidoscope prestained standards. 
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